IgA Nephropathy Clinical Trials

• Pilot Trial of Treatment of Poor-Prognosis Iga Nephropathy With Low Exposure to Sirolimus.
  ClinicalTrials.gov Identifier: NCT00396721 - Recruiting
  Glomerulonephritis, IGA; Nephropathy, IGA; IGA Nephropathy
  
• Study to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00549692 - Recruiting
  IGA Nephropathy
  
• Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00318474 - Recruiting
  IGA Nephropathy
  
• Calcitriol in the Treatment of IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00319761 - Active, not recruiting
  IGA Nephropathy
  
• Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00554502 - Not yet recruiting
  IGA Nephropathy
  
• A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00426348 - Recruiting
  Glomerulonephritis, IGA
  
• Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00301600 - Completed
  IGA Nephropathy
  
• Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
  ClinicalTrials.gov Identifier: NCT00367562 - Completed
  IGA Nephropathy
  
• Rituximab in Progressive IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00498368 - Not yet recruiting
  IGA Nephropathy
  
• Alternate Day Prednisone or Daily Fish Oil Supplements in Patients with Immunoglobulin A Nephropathy
  ClinicalTrials.gov Identifier: NCT00004448 - Active, not recruiting
  IGA Glomerulonephritis
  
• ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT
  ClinicalTrials.gov Identifier: NCT00378443 - Active, not recruiting
  Glomerulonephritis, IGA
  
• Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
  ClinicalTrials.gov Identifier: NCT00437463 - Active, not recruiting
  Glomerulonephritis
  
• Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00006137 - Completed
  IGA Glomerulonephritis
  
• Airway IgA: Respiratory Tract IgA Levels in Anesthetized Patients Undergoing Elective Surgical Procedures
  ClinicalTrials.gov Identifier: NCT00205361 - Recruiting
  Healthy; Malnutrition
  
• Nephropathy In Type 2 Diabetes and Cardio-Renal Events
  ClinicalTrials.gov Identifier: NCT00535925 - Active, not recruiting
  Diabetic Nephropathy
  
• Airway IgA: Respiratory Tract IgA Levels in Critically Ill Intubated Patients
  ClinicalTrials.gov Identifier: NCT00205309 - Recruiting
  Intubation; Critically Ill
  
• Effect of Sulodexide in Early Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00130208 - Active, not recruiting
  Diabetic Nephropathy
  
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
  ClinicalTrials.gov Identifier: NCT00141453 - Active, not recruiting
  Diabetic Nephropathy; type 2 diabeted mellitus; Proteinuria
  
• Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
  ClinicalTrials.gov Identifier: NCT00004305 - Completed
  IGA Glomerulonephritis
  
• Renoprotection in Early Diabetic Nephropathy in Pima Indians
  ClinicalTrials.gov Identifier: NCT00340678 - Active, not recruiting
  Diabetic Nephropathy
  
• Delaying the Progression of Diabetic Nephropathy in Pima Indians
  ClinicalTrials.gov Identifier: NCT00353600 - Active, not recruiting
  Diabetic Nephropathy
  
• Effect of Sulodexide in Overt Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00130312 - Recruiting
  Diabetic Nephropathy
  
• Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00253786 - Recruiting
  Type 2 Diabetes Mellitus; Diabetic Nephropathy
  
• Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients
  ClinicalTrials.gov Identifier: NCT00467311 - Recruiting
  Contrast Induced Nephropathy; Acute Renal Failure
  
• Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
  ClinicalTrials.gov Identifier: NCT00513825 - Recruiting
  Contrast Induced Nephropathy
  
• Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
  ClinicalTrials.gov Identifier: NCT00312117 - Recruiting
  Contrast Induced Nephropathy; Kidney Diseases
  
• EUROPEAN TRIAL OF IMMUNOSUPPRESSION IN SPK Tx.
  ClinicalTrials.gov Identifier: NCT00140543 - Active, not recruiting
  Diabetes Mellitus, Type 1; Diabetic Nephropathy
  
• Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00419835 - Recruiting
  Macroalbuminuric Diabetic Nephropathy
  
• The genetics of kidneys in diabetes (GoKinD) study
  ClinicalTrials.gov Identifier: NCT00024921 - Recruiting
  Diabetic Nephropathy
  
• Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
  ClinicalTrials.gov Identifier: NCT00476619 - Recruiting
  Contrast Induced Nephropathy
  
• ARIA(Atacand Renoprotection In NephropAthy Pt.)
  ClinicalTrials.gov Identifier: NCT00573430 - Not yet recruiting
  Non-Diabetic Nephropathy With Hypertension
  
• Safety Study Of N-ac For The Prevention Of Contrast Induced Nephropathy (CIN) In Patients With Stage 3 Renal Failure
  ClinicalTrials.gov Identifier: NCT00575419 - Recruiting
  Contrast Induced Nephropathy
  
• Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-Acetylcysteine
  ClinicalTrials.gov Identifier: NCT00353340 - Recruiting
  Acute Renal Failure Contrast Nephropathy
  
• Rituximab in Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00425217 - Active, not recruiting
  Membranous Nephropathy
  
• Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)
  ClinicalTrials.gov Identifier: NCT00514150 - Recruiting
  Contrast Induced Nephropathy
  
• Rituximab in the Treatment of Idiopathic Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00405340 - Recruiting
  Membranous Nephropathy
  
• Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
  ClinicalTrials.gov Identifier: NCT00540904 - Recruiting
  Contrast Induced Nephropathy
  
• Sulodexide to Treat Type 2 Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00342238 - Recruiting
  Overt Type 2 Diabetic Nephropathy; Chronic Kidney Disease; Diabetes Type 2
  
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00312780 - Recruiting
  Albuminuria; Diabetic Nephropathy
  
• Matrix metalloproteinases and Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00067886 - Recruiting
  Diabetes Mellitus, Type 1; Diabetic Nephropathy
  
• Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
  ClinicalTrials.gov Identifier: NCT00342927 - Recruiting
  Nephropathy; Diabetes
  
• Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
  ClinicalTrials.gov Identifier: NCT00497666 - Not yet recruiting
  Diabetes; Diabetic Nephropathy; Renal Protection
  
• Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00302523 - Recruiting
  Idiopathic Membranous Nephropathy
  
• Sodium Bicarbonate in Preventing Contrast Induced Nephropathy
  ClinicalTrials.gov Identifier: NCT00531765 - Recruiting
  Contrast Induced Nephropathy
  
• Cidofovir and BKVN in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00138424 - Recruiting
  BK virus (nephropathy)
  
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00324675 - Recruiting
  Type 2 Diabetes; Overt Diabetic Nephropathy
  
• Effects of Mycophenolate Mofetil On Anti-HLA Antibody Levels In Patients Awaiting Cadaveric Renal Transplant
  ClinicalTrials.gov Identifier: NCT00446459 - Active, not recruiting
  Kidney Failure, Chronic; Diabetic Nephropathies; Glomerulonephritis, IGA; Hypertension, Renal
  
• Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00153621 - Recruiting
  Chronic Kidney Failure; AIDS-Associated Nephropathy
  
• Pirfenidone: A New Drug to Treat Kidney Disease in Patients with Diabetes
  ClinicalTrials.gov Identifier: NCT00063583 - Recruiting
  Diabetes Mellitus; Diabetic Nephropathy
  
• Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
  ClinicalTrials.gov Identifier: NCT00392405 - Not yet recruiting
  Contrast Induced Nephropathy
  
• The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
  ClinicalTrials.gov Identifier: NCT00494637 - Not yet recruiting
  Contrast Induced Nephropathy
  
• Effects of Rituximab and Mycophenolate Mofetil on Anti-Donor Antibody Production in Patients Awaiting Transplant
  ClinicalTrials.gov Identifier: NCT00446251 - Recruiting
  Kidney Failure, Chronic; Diabetic Nephropathies; Glomerulonephritis, IGA; Hypertension, Renal
  
• Genetic Markers for Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00001393 - Recruiting
  AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
  
• Benfotiamine in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00565318 - Not yet recruiting
  Diabetic Nephropathy
  
• Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00188955 - Active, not recruiting
  Kidney Transplantation
  
• Eplerenone, ACE Inhibition and Albuminuria
  ClinicalTrials.gov Identifier: NCT00315016 - Recruiting
  Diabetic Nephropathy
  
• Statins in Proteinuric Nephropathies
  ClinicalTrials.gov Identifier: NCT00199927 - Recruiting
  Chronic Nephropathy; Proteinuria; Hypertension
  
• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
  ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
  Hypertension; Diabetic Nephropathy
  
• Cause of Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00001392 - Recruiting
  AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
  
• To Compare the Efficacy and Safety of TW vs Valsartan in the MN
  ClinicalTrials.gov Identifier: NCT00518219 - Recruiting
  Membranous Nephropathy
  
• To Compare the Efficacy and Safety of TW vs Valsartan in the DN
  ClinicalTrials.gov Identifier: NCT00518362 - Recruiting
  Diabetic Nephropathy
  
• Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00556465 - Completed
  Diabetic Nephropathy; Chronic Kidney Disease; Diabetes Type 2
  
• Olmesartan Medoxomil and Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00362960 - Completed
  Type 2 Diabetes Mellitus; Diabetic Nephropathy; Proteinuria; Renal Disease
  
• Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
  ClinicalTrials.gov Identifier: NCT00472563 - Recruiting
  Acute Kidney Failure
  
• Treatment of Patients with Idiopathic Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00135954 - Active, not recruiting
  Glomerulonephritis, Membranous
  
• A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)
  ClinicalTrials.gov Identifier: NCT00000819 - Completed
  HIV Infections; AIDS-Associated Nephropathy
  
• Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephopathy
  ClinicalTrials.gov Identifier: NCT00521508 - Not yet recruiting
  Pathogenesis of Berger's Disease
  
• Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
  ClinicalTrials.gov Identifier: NCT00424320 - Recruiting
  Acute Kidney Failure
  
• Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00311870 - Completed
  Diabetic Nephropathy
  
• 6-Month Safety and Efficacy Study of TTP488 in Patients With Type 2 Diabetes and Persistent Albuminuria
  ClinicalTrials.gov Identifier: NCT00287183 - Recruiting
  Diabetic Nephropathy
  
• Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
  ClinicalTrials.gov Identifier: NCT00558142 - Recruiting
  Radiocontrast-Induced Nephropathy
  
• Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
  ClinicalTrials.gov Identifier: NCT00462202 - Recruiting
  Diabetic Nephropathy
  
• Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
  ClinicalTrials.gov Identifier: NCT00317252 - Recruiting
  Kidney Failure
  
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00568477 - Active, not recruiting
  Grafting; Renal Transplantation; Transplantation, Kidney; Chronic Allograft Nephropathy
  
• To Determine the Effects of Avosentan On Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00120328 - Terminated
  Diabetic Nephropathy
  
• Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00050713 - Active, not recruiting
  Membranous Glomerulonephritis
  
• Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
  ClinicalTrials.gov Identifier: NCT00492518 - Completed
  Contrast Induced Nephropathy; Kidney Diseases; Renal Failure; Adverse Effects
  
• Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy
  ClinicalTrials.gov Identifier: NCT00309127 - Completed
  Type 2 Diabetes Mellitus; DM Nephropathy
  
• Safety and Efficacy of Aliskiren in Patients with Hypertension, Type 2 Diabetes and Proteinuria
  ClinicalTrials.gov Identifier: NCT00097955 - Completed
  Diabetic Nephropathy
  
• The Use of Cilostazol in Patients With Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00272831 - Recruiting
  Diabetes Mellitus, Type 2; Diabetes Complications
  
• New Strategies for Non-Invasive Detection of Chronic Allograft Nephropathy
  ClinicalTrials.gov Identifier: NCT00283348 - Recruiting
  Chronic Rejection
  
• Bicarbonate v Saline to Prevent Contrast Nephropathy
  ClinicalTrials.gov Identifier: NCT00384995 - Recruiting
  Kidney Failure, Acute; Contrast Media
  
• The Effect of LY333531 on Protein in the Urine in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00044148 - Completed
  Diabetic Nephropathy
  
• Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00494715 - Recruiting
  Diabetes
  
• Trial to Compare Infarct Size and Occurrence of Contrast Dye Induced Nephropathy in Patients With Primary Percutaneous Coronary Intervention for STEMI
  ClinicalTrials.gov Identifier: NCT00463749 - Recruiting
  Myocardial Infarction
  
• Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
  ClinicalTrials.gov Identifier: NCT00541814 - Recruiting
  Chronic Allograft Nephropathy
  
• Effect of Pyridorin in Patients With Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00320021 - Completed
  Diabetic Nephropathy
  
• Effect of Pyridorin in Patients With Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00320060 - Completed
  Diabetic Nephropathy
  
• Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00498537 - Completed
  Diabetic Nephropathy
  
• A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
  ClinicalTrials.gov Identifier: NCT00579995 - Recruiting
  Preserving Kidney Function in People Who Are at High Risk of Developing Contrast-Induced Nephropathy
  
• Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy
  ClinicalTrials.gov Identifier: NCT00361023 - Completed
  Type 2 Diabetes; Diabetic Nephropathy
  
• Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With LPD in Delaying the Progress of Type 2 DN
  ClinicalTrials.gov Identifier: NCT00363987 - Recruiting
  Nephropathy With Type 2 Diabetes
  
• A Study of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Being Treated With Renin-Angiotensin System Inhibitors
  ClinicalTrials.gov Identifier: NCT00421733 - Recruiting
  Diabetic Nephropathies
  
• Study of Drugs for High Blood Pressure and High Cholesterol in American Indians with Type 2 Diabetes at High Risk of Kidney or Heart Disease
  ClinicalTrials.gov Identifier: NCT00004266 - Completed
  Diabetic Nephropathy
  
• Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage
  ClinicalTrials.gov Identifier: NCT00313807 - Recruiting
  Contrast Nephropathy; Renal Failure
  
• Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy
  ClinicalTrials.gov Identifier: NCT00464776 - Recruiting
  Diabetes Type 2
  
• Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study
  ClinicalTrials.gov Identifier: NCT00222846 - Recruiting
  Diabetes Mellitus, Type 2; Diabetic Nephropathy
  
• Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
  ClinicalTrials.gov Identifier: NCT00404833 - Recruiting
  Glomerulonephritis, Membranous; Glomerulosclerosis, Focal
  
• Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
  ClinicalTrials.gov Identifier: NCT00390585 - Recruiting
  Renal Insufficiency, Chronic; Angioplasty, Transluminal, Percutaneous Coronary; Coronary Arteriosclerosis
  
• Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00237952 - Recruiting
  Diabetic Nephropathies; Diabetes Mellitus, Type II